CompletedPhase 4ACTRN12611000569909
Oral Silodosin on Lower Urinary Tract Symptoms Due to Double-J stent: A Prospectively Randomized Study
Oral silodosin on lower urinary tract symptoms due to double-J stent
Sponsor
Chung Jing Wang
Enrollment
45 participants
Start Date
Nov 1, 2010
Study Type
Interventional
Conditions
Summary
a randomized double-blinded controlled study to evaluate the effect of silodosin in improving symptoms and quality of life in patients with indwelling double-J ureteral stents using specific questionnaire
Eligibility
Sex: Both males and femalesMin Age: 20 YearssMax Age: 60 Yearss
Inclusion Criteria1
- patients, with insertion of a double-J ureteral stent after ureteroscopic stone removal, were enrolled into the study
Exclusion Criteria1
- benign prostatic hyperplasia-related lower urinary symptoms(International Prostate Symptom Score greater greater than 7); a history of interstitial cystitis, chronic cystitis, chronic prostatitis, or stent insertion; and chronic medication with alpha-blockers or analgesics
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
daily oral silodosin 4 mg for 2 weeks in improving symptoms and quality of life in patients with indwelling double-J ureteral stents using specific questionnaire
daily oral silodosin 4 mg for 2 weeks in improving symptoms and quality of life in patients with indwelling double-J ureteral stents using specific questionnaire
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12611000569909